Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Rectal Neoplasms × Methods × Clear all

Phase

Phase NA 7 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Hematologic Neoplasms 2 Head and Neck Neoplasms 2 Rectal Neoplasms 1 Pain 1 Neoplasms 1 Mucositis 1 Lymphoma 1 Fallopian Tube Neoplasms 1 Carcinoma in Situ 1 Brenner Tumor 1 Anatomic Stage I Breast Cancer AJCC v8 1 Abnormalities, Radiation-Induced 1

Interventions

Fluorouracil 51 Leucovorin 47 Oxaliplatin 41 Capecitabine 34 Irinotecan 24 Radiotherapy 15 Bevacizumab 15 Folfox protocol 11 Chemoradiotherapy 11 Neoadjuvant Therapy 9 Chemotherapy, Adjuvant 9 Cetuximab 8 Surgical Procedures, Operative 5 Drug Therapy 5 XELOX 4 Panitumumab 4 Laparoscopy 4 FOLFOXIRI protocol 4 Transanal Endoscopic Microsurgery 3 Radiation 3 Octreotide 3 IFL protocol 3 Floxuridine 3 Diathermy 3 Trinitrotoluene 2 Tegafur 2 Proctectomy 2 Occult Blood 2 Loperamide 2 Levamisole 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04288999 2020-06-04

JCOG1801

National Cancer Center Hospital East

Phase 3 Recruiting

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡